Hervé TILLY, MD
CHU Rouen · Centre Henri Becquerel, Rouen, France - LYSA · Lymphoma Study Association
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hervé TILLY, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:34 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03946332 · Physical Activity for Myeloma Autograft Longitudinal StudyCentre Hospitalier Universitaire, Amiens · terminated · Physical Activity, Multiple Myeloma, Quality of Life · principal investigator
- Ph1NCT02741388 · A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDPThe Lymphoma Academic Research Organisation · completed · B-cell Lymphoma · study chair
- Ph2NCT00847223 · Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell LymphomaLymphoma Study Association · terminated · Mantle Cell Lymphoma · principal investigator
- Ph2NCT00144807 · ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell LymphomaLymphoma Study Association · completed · Diffuse Large Cell Lymphoma · study chair
- Ph3NCT00144755 · R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell LymphomaLymphoma Study Association · completed · Diffuse Large Cell Lymphoma · study chair
- Ph3NCT00140595 · ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1Lymphoma Study Association · completed · Diffuse Large-Cell Lymphoma · study chair
- Ph3NCT00140660 · ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell LymphomaLymphoma Study Association · terminated · Diffuse Large Cell Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.